190 related articles for article (PubMed ID: 25623255)
1. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro.
Safa M; Kazemi A; Zaker F; Razmkhah F
J Recept Signal Transduct Res; 2011 Jun; 31(3):256-63. PubMed ID: 21619452
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL.
Naderi EH; Ugland HK; Diep PP; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Blood; 2013 Mar; 121(10):1805-13. PubMed ID: 23299313
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of Epac1/Rap1/Akt and PKA in prostaglandin E(2) -induced proliferation of human umbilical cord blood derived mesenchymal stem cells: involvement of c-Myc and VEGF expression.
Jang MW; Yun SP; Park JH; Ryu JM; Lee JH; Han HJ
J Cell Physiol; 2012 Dec; 227(12):3756-67. PubMed ID: 22378492
[TBL] [Abstract][Full Text] [Related]
5. Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation.
Naderi EH; Findley HW; Ruud E; Blomhoff HK; Naderi S
Blood; 2009 Jul; 114(3):608-18. PubMed ID: 19451550
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling.
Hsiao HY; Mak OT; Yang CS; Liu YP; Fang KM; Tzeng SF
Glia; 2007 Jan; 55(2):214-23. PubMed ID: 17091492
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
8. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML
Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337
[TBL] [Abstract][Full Text] [Related]
9. cAMP signalling inhibits p53 acetylation and apoptosis via HDAC and SIRT deacetylases.
Kloster MM; Naderi EH; Haaland I; Gjertsen BT; Blomhoff HK; Naderi S
Int J Oncol; 2013 May; 42(5):1815-21. PubMed ID: 23483263
[TBL] [Abstract][Full Text] [Related]
10. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells.
Kihira K; Chelakkot VS; Kainuma H; Okumura Y; Tsuboya N; Okamura S; Kurihara K; Iwamoto S; Komada Y; Hori H
Int J Hematol; 2020 Dec; 112(6):795-806. PubMed ID: 32862292
[TBL] [Abstract][Full Text] [Related]
11. Relative genomic stability of adipose tissue derived mesenchymal stem cells: analysis of ploidy, H19 long non-coding RNA and p53 activity.
Ravid O; Shoshani O; Sela M; Weinstock A; Sadan TW; Gur E; Zipori D; Shani N
Stem Cell Res Ther; 2014 Dec; 5(6):139. PubMed ID: 25519840
[TBL] [Abstract][Full Text] [Related]
12. cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53.
Skah S; Richartz N; Duthil E; Gilljam KM; Bindesbøll C; Naderi EH; Eriksen AB; Ruud E; Dirdal MM; Simonsen A; Blomhoff HK
Oncotarget; 2018 Jul; 9(54):30434-30449. PubMed ID: 30100998
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of intercellular adhesion between B-cell precursor acute lymphoblastic leukemic cells and bone marrow stromal cells.
Ashley DM; Bol SJ; Tucker DP; Waugh CM; Kannourakis G
Leukemia; 1995 Jan; 9(1):58-67. PubMed ID: 7845030
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
16. Hyperactivation of NF-κB via the MEK signaling is indispensable for the inhibitory effect of cAMP on DNA damage-induced cell death.
Kloster MM; Naderi EH; Carlsen H; Blomhoff HK; Naderi S
Mol Cancer; 2011 Apr; 10():45. PubMed ID: 21510868
[TBL] [Abstract][Full Text] [Related]
17. Rat bone marrow mesenchymal stem cells undergo malignant transformation via indirect co-cultured with tumour cells.
Liu J; Zhang Y; Bai L; Cui X; Zhu J
Cell Biochem Funct; 2012 Dec; 30(8):650-6. PubMed ID: 22763674
[TBL] [Abstract][Full Text] [Related]
18. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
Martinet L; Jean C; Dietrich G; Fournié JJ; Poupot R
Biochem Pharmacol; 2010 Sep; 80(6):838-45. PubMed ID: 20470757
[TBL] [Abstract][Full Text] [Related]
19. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation.
Bauman GP; Bartik MM; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):182-94. PubMed ID: 8087864
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis.
Roper RL; Phipps RP
J Immunol; 1992 Nov; 149(9):2984-91. PubMed ID: 1328389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
